The start-up company Allogenetics GmbH offers a completely new solution to the problem of organ rejection in transplantation. The Allogenetics approach is a unique first-in-class therapeutics as it treats the transplant instead of paralyzing the patient's immune system. This disruptive innovation offers a new dimension in organ transplantation: Invisible organs instead of lifelong immunosuppression.